Rhenman & Partners Asset Management AB - STEMLINE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$3,146,000
-61.1%
650,000
-14.5%
0.44%
-50.2%
Q4 2019$8,081,000
+51.9%
760,181
+48.8%
0.89%
+32.8%
Q3 2019$5,320,000
-29.7%
511,023
+3.4%
0.67%
-20.0%
Q2 2019$7,568,000–493,999–0.83%–
 Download
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders